Enovix Corporation vs Herbalife Nutrition Ltd — how do they compare? Enovix Corporation trades at $2.47 (market cap $549.72M), while Herbalife Nutrition Ltd trades at $12.92 (market cap $1.34B). The key difference: Herbalife Nutrition Ltd is far larger — about 2.4× Enovix Corporation's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Herbalife Nutrition Ltd for 43 Days on average.
| ENVX | HLF | |
|---|---|---|
Market Cap | $549.72M | $1.34B |
Volume | 6,635,687 | 1,589,457 |
Sector | Industrials | Consumer Staples |
52-Week High | $13.19 | $19.96 |
52-Week Low | $2.50 | $7.75 |
Typical Hold Time | 11 Days | 43 Days |
Enterprise Value | $611.42M | $3.18B |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.485, down 2.55% on the day, reflecting a bearish technical outlook. The company continues to post significant losses, with a net income margin of -473.89% in 2026, though quarterly earnings have consistently beaten expectations. Recent news is dominated by a sudden CEO transition, but the company reaffirmed its strategy and guidance, highlighting progress in its drone and defense battery supply chain.
The outlook is highly speculative. Analyst consensus is bullish with a $10.75 price target, but substantial execution risks and persistent cash burn pose a threat to shareholder value. Investment potential hinges on successful commercialization and achieving profitability, which remains distant.
Herbalife (HLF) trades at $12.86, up 1.62% on the day, with a bullish technical signal and a consensus analyst price target of $19.00 implying significant upside. The company reported Q2 2026 EPS of $0.51, missing expectations, but reaffirmed full-year 2026 guidance. Financials show a net income margin of 3.16% for 2025, with a low P/E of 8.22 and P/S of 0.26, suggesting potential undervaluation. Recent news includes a $250 million share repurchase authorization and a planned CEO transition effective October 31, 2026.
The outlook for HLF is cautiously optimistic, with valuation metrics and analyst sentiment supporting a bullish case, but risks include recent earnings misses, high debt levels, and ongoing leadership changes. The stock presents a value opportunity if the company can execute on its growth and margin expansion plans while managing its leverage.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →